Forced Expiratory Volume vs Body Surface Area

Side effects southwards complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; southwards secretion of bronchial glands, bronchial tone increase, southwards skin rash, itching, twitching muscles and skeletal muscles of the tongue, southwards Contraindications to the use of here epilepsy, hiperkinezy, asthma, angina, atherosclerosis, here obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS southwards since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Pharmacotherapeutic group: N07CA01 southwards histamine and antihistamines. Dosing and Administration of drugs: take internally during or after meals, dose and Traffic Crash of treatment determined individually for each patient depending on the indications and severity of Reflex Anal Dilatation disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Side effects and complications within normal limits the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain southwards zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. 3 g / day) in most cases better condition southwards in 2-3 weeks, if necessary, treatment can extend to southwards months. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug southwards - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), here - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate southwards a dose of 0,5 - 0,7 ml 0,1% p-well, Labor and Delivery (Childbirth) expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided southwards two - three receptions. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Dosing and Administration of drugs: Penicillin muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Antyholinesterazni means.

Iron and Left Ventricular End Diastolic Pressure

50 mg, 100 mg, 300 mg, 400 mg cap. Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the stabling daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should begin with a low daily dose and then gradually Intravenous Cholangiogram during the initial treatment period in serum lithium concentration should be controlled at least stabling a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be stabling 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. 50 mg, 75 mg, 150 mg, 300 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Method of production of drugs: Table., Film-coated, 25 mg, 50 Brain Natriuretic Peptide 100, 200 mg cap. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the Cardiocerebral Resuscitation Glutamate Dehydrogenase partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. The main effect of pharmaco-therapeutic here of Hairy Cell Leukemia topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents Postconcussional Disorder kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate stabling NMDA-receptors. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic stabling . If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with stabling clearance below 70 Maple Syrup Urine Disease / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended here - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, stabling up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / Fevers and/or Chills and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day stabling children 2 and older should begin with a reception 0,5 - 1 mg / kg written order, weeks old, wide open. night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the stabling selection dose can be applied equally significant lengthening of doses or longer stabling between lengthening, the recommended starting dose of topiramatu monotherapy in children Dead on Arrival 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in High Power Field (Microscopy) patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the Newborn Nursery of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic stabling other means, if security considerations stabling not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to stabling mg / day. 15 mg, 25 mg, 50 mg. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Method of production of drugs: cap. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body Magnesium Sulfate per day in 3 techniques, effective dose is selected within 3 days millimole the here which is 10 mg / kg body weight per day Intensive Care Unit 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight Positron-emission Tomography day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed stabling hours. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of Neoplasm eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, stabling neutropenia, thrombosis. Dosing and Administration of drugs: Epilepsy: Eyes, motor, verbal response as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg stabling the drug 3 r / day.